Skip to main content
. Author manuscript; available in PMC: 2019 Apr 4.
Published in final edited form as: Best Pract Res Clin Haematol. 2012 Oct 25;25(4):465–471. doi: 10.1016/j.beha.2012.10.009

Figure 1.

Figure 1.

The figure on the left shows the probability of death not preceded by relapse, and the figure on the right shows overall survival for patients receiving allogeneic HCT in Seattle from 1993–1997 (n=1418) and 2003–2007 (n=1148) [4]. From New England Journal of Medicine, Gooley TA, Chien JW, Pergam SA, et al, Reduced mortality after allogeneic hematopoietic-cell transplantation. Volume 363, Page 2098, Copyright © 2010 Massachusetts Medical Society. Reprinted with permission from Massachusetts Medical Society.